Medically Qualified Translators
Every Polish medical project is handled by a translator with a proven background in medicine, pharmacology, or life sciences.
Poland is one of the most active clinical trial markets in Central Europe, hosting a significant number of Phase II and Phase III studies for global pharmaceutical companies. The Polish regulatory authority (URPL) has specific submission requirements, and Polish clinical trial sites require accurate, clearly written patient-facing materials.
Our Polish medical translators hold degrees in medicine, pharmacology, or life sciences and are fully fluent in URPL submission standards and EU clinical trial regulations.
Polish-speaking participants in medical conferences and staff training can be supported by expert interpreting services, in the room or by remote interpreting, booked together with the translation. Hospital records and physician letters bound for a US hospital or a hospital in Europe are a separate case, and certified document translations can be ordered with the rest of the project. The recipient sets the requirements, so share them early.

Every Polish medical project is handled by a translator with a proven background in medicine, pharmacology, or life sciences.
Translation, editing by a second medical linguist, and a final terminology check against validated Polish medical glossaries and URPL terminology lists.
Familiar with Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) submission requirements and EU clinical trial regulations applicable in Poland.
Patient information sheets and informed consent forms receive additional review for accuracy and clarity for Polish-speaking patients.
“They offer great and reasonable prices for sworn translations. Thank you for your help in translating my documents for my legal process.”
“Great communication, perfect translations in different languages in a very short notice. I would recommend! We are very pleased, thank you :-)”
“We regularly use BeTranslated's translation services and are very satisfied with their work. The team is professional and highly efficient! We highly recommend them.”
Yes. We have experience with URPL submissions and follow the Office's formatting requirements for Polish drug registration and marketing authorization dossiers.
Yes. We manage multi-site projects with dedicated project managers ensuring consistent terminology and formatting across all Polish trial locations.
The time for an informed consent form of 10 to 20 pages depends on length, language pair and subject, and is confirmed in the quote. Urgent turnaround is available when the protocol timeline requires it.
Yes. The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) has specific Polish-language document structure and terminology requirements.
Our Polish medical translators follow URPL formatting guidance for drug registration dossiers and the EU Clinical Trials Regulation requirements applicable to Polish sites. Polish clinical trial documentation also requires compliance with the Bioethics Committee (Komisja Bioetyczna) submission standards.
All translators and project managers sign GDPR-aligned data processing agreements before receiving any patient-identifiable material. Poland's UODO (Urzad Ochrony Danych Osobowych) implements EU GDPR requirements in Polish law; we apply these requirements as the baseline for all Polish health data projects.
Files are transferred over encrypted channels and purged from our systems on project closure unless you request translation memory retention.
Send us your files, language pairs, and deadline. We will confirm specialist availability, certification needs, and a clear quote as quickly as possible.